We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

An illustration of a magnifying glass. An illustration of a magnifying glass.

Jefferies analyst David Shang maintained a Hold rating on CSPC Pharmaceutical Group (CHJTF – Research Report) today and set a price target of HK$4.60. The company’s shares closed last Monday ...

Of course, some criticize these modern logos as being copy-and-paste, minimalist and unoriginal. Those yearn to return to the unique logos of the 1990s and early 2000s, where the NFL used elements ...

CSPC Pharmaceutical Group (CSPC) is a pharmaceutical company, which provides innovative, generic and bulk drugs. The company manufactures, research and markets medicines and pharmaceutical related ...

SYS-6010 is under clinical development by CSPC Pharmaceutical Group and currently in Phase I for Breast Cancer. According to GlobalData, Phase I drugs for Breast Cancer have a 72% phase transition ...

Overview: CSPC Pharmaceutical Group Limited is an investment holding company involved in the research, development, manufacture, and sale of pharmaceutical products across China and ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...